אבירטרון טבע 500 מ"ג
ABIRATERONE TEVA 500 MG

פעילות רפואית

Abiraterone Teva is indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer. Abiraterone Teva is indicated for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men in combination with androgen deprivation therapy (ADT).